Stocks · Korea
012790
KOSDAQ
Shinil Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER10.03x
PBR0.50x
EPS651 KRW
BPS13,180 KRW
ROE4.52%
Dividend yield2.91%
DPS190 KRW
Payout ratio29.19%
Returns and 52-week range
1W+6.97%
1M+9.63%
3M+25.48%
6M+8.91%
1Y+5.60%
YTD+8.20%
52W high6,820원
52W low4,820원
From 52W high-3.23%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 800억 | 137억 | 122억 | 17.1% |
| 2023 | 891억 | 140억 | 136억 | 15.7% |
| 2024 | 894억 | 152억 | 143억 | 17.0% |
| 2025 | 806억 | 74억 | 75억 | 9.2% |
| Quarterly | ||||
| 2024 4Q | 215억 | 40억 | 39억 | 18.8% |
| 2025 1Q | 192억 | 20억 | 20억 | 10.2% |
| 2025 2Q | 196억 | 32억 | 28억 | 16.2% |
| 2025 3Q | 206억 | 27억 | 26억 | 12.9% |
| 2025 4Q | 211억 | -4억 | 1억 | -2.0% |
| 2026 1Q | 209억 | 13억 | 14억 | 6.4% |
Company
Address: 충북 충주시 앙성면 본평리 산 5-1
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.